SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia.

SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia. J Clin Oncol. 2022 05 10; 40(14):1574-1582.

View in: PubMed

subject areas

Aged
Antibodies, Bispecific
Antineoplastic Combined Chemotherapy Protocols
Humans
Lymphoma, B-Cell
Methotrexate
Philadelphia Chromosome
Precursor Cell Lymphoblastic Leukemia-Lymphoma

authors with profiles

Wendy Stock